ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,221Medicare Part D Prescriptions Filled, Including Refills

Rank: 263 out of 1383

$721K Total Retail Price of All Prescriptions

Rank: 146 out of 1383

516 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 7,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 609 393 1 3
HYDROCODONE-ACETAMINOPHEN 495 290 S3 2 1
METOPROLOL TARTRATE 376 237 3 9
SIMVASTATIN 323 171 4 2
OMEPRAZOLE 317 254 5 5
AMLODIPINE BESYLATE 271 193 6 6
METFORMIN HCL 256 173 7 8
RANITIDINE HCL 242 172 8 19
PRAVASTATIN SODIUM 236 142 9 14
LEVOTHYROXINE SODIUM 214 129 10 4
FUROSEMIDE 210 120 11 7
HYDROCHLOROTHIAZIDE 209 134 12 10
LOVASTATIN 181 143 13 22
CARVEDILOL 173 98 14 24
CITALOPRAM HBR 156 99 15 15
FLUTICASONE PROPIONATE 153 88 16 39
PANTOPRAZOLE SODIUM 147 101 17 32
NEXIUM 143 88 18 26
PREDNISONE 136 90 19 40
GABAPENTIN 134 102 20 11
SPIRIVA 126 83 21 45
WARFARIN SODIUM 122 95 22 13
JANTOVEN 117 79 23 146
ZOLPIDEM TARTRATE 111 72 24 17
DOXYCYCLINE HYCLATE 107 74 25 94
GLIMEPIRIDE 103 56 26 31
LANTUS 99 70 27 50
AMITRIPTYLINE HCL 93 38 R 28 57
ROPINIROLE HCL 90 43 29 79
TAMSULOSIN HCL 87 68 30 30
FLUOXETINE HCL 83 63 31 52
POTASSIUM CHLORIDE 81 49 32 12
CLOPIDOGREL 78 53 33 28
GLYBURIDE 77 39 R 34 46
QUETIAPINE FUMARATE 76 68 35 70
CRESTOR 75 47 36 34
ZETIA 70 58 37 101
ATENOLOL 69 46 38 16
BENAZEPRIL HCL 66 66 39 38
LOSARTAN POTASSIUM 66 34 39 23
TRAMADOL HCL 64 50 41 25
CIPROFLOXACIN HCL 64 50 41 54
MELOXICAM 63 43 43 20
SPIRONOLACTONE 60 39 44 67
NAMENDA 60 60 44 49
VENTOLIN HFA 58 36 46 93
PROAIR HFA 54 29 47 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 48 47 27
LYRICA 53 0 49 72
SINGULAIR 53 33 49 82
PAROXETINE HCL 53 34 49 55
INSULIN SYRINGE 51 30 52 83
DEXILANT 51 12 52 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.